Russia's Cancer Vaccine Shows 100% Efficacy In Trials: Ready For Use: Report | TimelineDaily | AI News Digest

Russia's cancer vaccine has demonstrated 100% efficacy in trials and is now ready for use, pending official approval. The vaccine, developed by the Federal Medical and Biological Agency (FMBA), represents a significant advancement in oncology, particularly as it is the world's first personalized mRNA-based melanoma vaccine. Researchers have reported safety and high efficacy, with significant reductions in tumor size and increased survival rates observed in trials. The initial focus will be on colorectal cancer, with ongoing development for other types of cancer.

More like this

Pediatrician Critiques Fssai's Decision on High-sugar ORS Disposal | AI News Digest

October 24, 2025

Bhopal Diwali Celebrations Lead to Over 60 Injuries From Carbide Guns | AI News Digest

October 23, 2025

New Guidelines on Peanut Introduction Reduce Allergy Cases in Children | AI News Digest

October 22, 2025

Innovative Eye Implant Restores Reading Ability for Blind Patients | AI News Digest

October 21, 2025

Cow Enters Bandipora Hospital, Security Concerns Emerge | AI News Digest

October 19, 2025

FSSAI Bans Misleading Use of ORS Term on Food Products Following Campaign | AI News Digest

October 18, 2025